MK
Therapeutic Areas
Taiho Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Domvanalimab + Zimberelimab | Gastrointestinal cancers | Phase 3 |
| Cancer Vaccines (with JFCR/NEC) | Various cancers | Discovery/Preclinical |
| LONSURF | Metastatic colorectal/gastric cancers | Commercial |